59 related articles for article (PubMed ID: 11362283)
1. PML and a tale of two drug companies.
Notes Undergr; 1995; (no 29):4-6. PubMed ID: 11362283
[TBL] [Abstract][Full Text] [Related]
2. Topotecan and PML: the limits of pharmaceutical industry research.
Learned J
Notes Undergr; 1996 Sep; (No 33):1-3. PubMed ID: 11363913
[TBL] [Abstract][Full Text] [Related]
3. Topotecan research moves forward at last.
Smart T
GMHC Treat Issues; 1995 Apr; 9(4):1-3. PubMed ID: 11362363
[TBL] [Abstract][Full Text] [Related]
4. Topotecan now available for HIV, PML research.
AIDS Treat News; 1995 Apr; (no 220):4. PubMed ID: 11362319
[TBL] [Abstract][Full Text] [Related]
5. Progressive multifocal leukoencephalopathy.
Bowers M
BETA; 1997 Sep; ():23-6. PubMed ID: 11364695
[TBL] [Abstract][Full Text] [Related]
6. PML update.
Crit Path AIDS Proj; 1997; (No 32):31. PubMed ID: 11364441
[TBL] [Abstract][Full Text] [Related]
7. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy.
McGuire D; Barhite S; Hollander H; Miles M
Ann Neurol; 1995 Mar; 37(3):395-9. PubMed ID: 7695239
[TBL] [Abstract][Full Text] [Related]
8. Making inroads on PML.
Smart T
GMHC Treat Issues; 1996 May; 10(5):10-2. PubMed ID: 11363582
[TBL] [Abstract][Full Text] [Related]
9. JC virus detection in the cerebrospinal fluid of AIDS patients with progressive multifocal leucoencephalopathy and monitoring of the antiviral treatment by a PCR method.
Matsiota-Bernard P; De Truchis P; Gray F; Flament-Saillour M; Voyatzakis E; Nauciel C
J Med Microbiol; 1997 Mar; 46(3):256-9. PubMed ID: 9126827
[TBL] [Abstract][Full Text] [Related]
10. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.
Gasnault J; Taoufik Y; Goujard C; Kousignian P; Abbed K; Boue F; Dussaix E; Delfraissy JF
J Neurovirol; 1999 Aug; 5(4):421-9. PubMed ID: 10463864
[TBL] [Abstract][Full Text] [Related]
11. Detection of JC virus in two African cases of progressive multifocal leukoencephalopathy including identification of JCV type 3 in a Gambian AIDS patient.
Stoner GL; Agostini HT; Ryschkewitsch CF; Mazló M; Gullotta F; Wamukota W; Lucas S
J Med Microbiol; 1998 Aug; 47(8):733-42. PubMed ID: 9877195
[TBL] [Abstract][Full Text] [Related]
12. CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Takegami T
Microbiol Immunol; 2017 Jun; 61(6):232-238. PubMed ID: 28463406
[TBL] [Abstract][Full Text] [Related]
13. JC virus DNA in cerebrospinal fluid samples from Brazilian AIDS patients with focal brain lesions without mass effect.
Fink MC; Penalva de Oliveira AC; Milagres FA; Vidal JE; Picerno-Pouza AF; Duarte Neto A; Pannuti CS
J Infect; 2006 Jan; 52(1):30-6. PubMed ID: 16368458
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient.
Major EO; Ault GS
Curr Opin Neurol; 1995 Jun; 8(3):184-90. PubMed ID: 7551117
[TBL] [Abstract][Full Text] [Related]
15. Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy.
Tornatore C; Berger JR; Houff SA; Curfman B; Meyers K; Winfield D; Major EO
Ann Neurol; 1992 Apr; 31(4):454-62. PubMed ID: 1316734
[TBL] [Abstract][Full Text] [Related]
16. Quantification of JC virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy--a longitudinal study.
Eggers C; Stellbrink HJ; Buhk T; Dörries K
J Infect Dis; 1999 Nov; 180(5):1690-4. PubMed ID: 10515834
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of human polyomavirus JC in Brazilian AIDS patients with and without progressive multifocal leukoencephalopathy.
Fink MC; de Oliveira AC; Romano CM; Vidal JE; Urbano PR; Tateno AF; Oliveira CM; de Albuquerque Luna EJ; Pannuti CS
J Clin Virol; 2010 May; 48(1):6-10. PubMed ID: 20335066
[TBL] [Abstract][Full Text] [Related]
18. Visual loss secondary to acquired immunodeficiency virus-related progressive multifocal leukoencephalopathy demonstrating clinical improvement with highly active antiretroviral therapy.
Diller R; Thompson K
Optometry; 2007 Feb; 78(2):63-70. PubMed ID: 17258160
[TBL] [Abstract][Full Text] [Related]
19. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.
Giudici B; Vaz B; Bossolasco S; Casari S; Brambilla AM; Lüke W; Lazzarin A; Weber T; Cinque P
Clin Infect Dis; 2000 Jan; 30(1):95-9. PubMed ID: 10619739
[TBL] [Abstract][Full Text] [Related]
20. [Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: the clinical, neuroimaging, virological and evolutive characteristics in 35 patients].
Asensi V; Cartón JA; Maradona JA; Oña M; Melón S; Martín-Roces ER; Asensi JM; Arribas JM
Med Clin (Barc); 1999 Sep; 113(6):210-4. PubMed ID: 10472609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
